A Wetpaint Site

Sign in to Wetpaint

Sign in or

Sometimes Marketing Isn't The Answer: Pfzer Abandons Diabetes Drug Exubera

Page Versions

Key: additions deletions

Showing 5 pages

	Date/Time	Made By	Edit Note	Type	Scope
	Jan 2 2008, 7:49 PM EST	cmdtracy		edit
Change: There were only format changes (bold, italics, etc.) in this version. See this version for details. (Word count: 245)
	Dec 20 2007, 4:30 PM EST	cmdtracy		edit	1 image added 1 image deleted
Change: There were only format changes (bold, italics, etc.) in this version. See this version for details. (Word count: 245)
	Dec 20 2007, 3:57 PM EST	cmdtracy		edit
Change: There were only format changes (bold, italics, etc.) in this version. See this version for details. (Word count: 245)
	Dec 20 2007, 3:04 PM EST	cmdtracy		edit	240 words added 1 image added
Change: Pfizer has announced that after spending $2.8 Billion on its diabetes drug--it would stop selling Exubera, its inhaled insulin, less than two years after introducing the drug. It is an unfathomable failure, in an amazingly short period of time. The Pfizer marketing machine had gone View changes from previous version. (Word count: 245)
	Dec 20 2007, 3:04 PM EST	cmdtracy		create	No content added or deleted.
Change: Created by cmdtracy Dec 20 2007, 3:04 PM EST for: no reason given

JavaScript must be enabled in order for you to contribute to this site.
To start contributing, enable JavaScript by changing your browser options, then try again.

Home